Literature DB >> 29076143

Leukaemic stem cell load at diagnosis predicts the development of relapse in young acute myeloid leukaemia patients.

Diana Hanekamp1, Barbara Denys2, Gertjan J L Kaspers3,4, Jeroen G Te Marvelde5, Gerrit Jan Schuurhuis1, Valerie De Haas6, Barbara De Moerloose7,8, Eveline S de Bont9, C Michel Zwaan10, Anja de Jong6, Barbara Depreter7,8,11, Tim Lammens7,8, Jan Philippé2,8,11, Jacqueline Cloos1,3, Vincent H J van der Velden5.   

Abstract

Entities:  

Keywords:  flow cytometry; immunophenotyping; leukaemic stem cells; paediatric acute myeloid leukaemia; prognosis

Mesh：

Substances：

Year:  2017        PMID： 29076143     DOI： 10.1111/bjh.14991

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells.

Authors:  Jialan Niu; Danyue Peng; Lingbo Liu
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

2.  Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Authors:  Daniel Kerage; Megan S F Soon; Brianna L Doff; Takumi Kobayashi; Michael D Nissen; Pui Yeng Lam; Graham R Leggatt; Stephen R Mattarollo
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

3.  2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.

Authors:  Michael Heuser; Sylvie D Freeman; Gert J Ossenkoppele; Francesco Buccisano; Christopher S Hourigan; Lok Lam Ngai; Jesse M Tettero; Costa Bachas; Constance Baer; Marie-Christine Béné; Veit Bücklein; Anna Czyz; Barbara Denys; Richard Dillon; Michaela Feuring-Buske; Monica L Guzman; Torsten Haferlach; Lina Han; Julia K Herzig; Jeffrey L Jorgensen; Wolfgang Kern; Marina Y Konopleva; Francis Lacombe; Marta Libura; Agata Majchrzak; Luca Maurillo; Yishai Ofran; Jan Philippe; Adriana Plesa; Claude Preudhomme; Farhad Ravandi; Christophe Roumier; Marion Subklewe; Felicitas Thol; Arjan A van de Loosdrecht; Bert A van der Reijden; Adriano Venditti; Agnieszka Wierzbowska; Peter J M Valk; Brent L Wood; Roland B Walter; Christian Thiede; Konstanze Döhner; Gail J Roboz; Jacqueline Cloos
Journal:  Blood       Date:  2021-12-30       Impact factor: 22.113

4.  High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML.

Authors:  Shruti Daga; Angelika Rosenberger; Franz Quehenberger; Nina Krisper; Barbara Prietl; Andreas Reinisch; Armin Zebisch; Heinz Sill; Albert Wölfler
Journal:  Cancer Med       Date:  2019-03-07       Impact factor: 4.452

5.  TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment.

Authors:  Barbara Depreter; Karin E Weening; Karl Vandepoele; Magnus Essand; Barbara De Moerloose; Maria Themeli; Jacqueline Cloos; Diana Hanekamp; Ine Moors; Inge D'hont; Barbara Denys; Anne Uyttebroeck; An Van Damme; Laurence Dedeken; Sylvia Snauwaert; Glenn Goetgeluk; Stijn De Munter; Tessa Kerre; Bart Vandekerckhove; Tim Lammens; Jan Philippé
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

Review 6.  TARP as antigen in cancer immunotherapy.

Authors:  Jolien Vanhooren; Charlotte Derpoorter; Barbara Depreter; Larissa Deneweth; Jan Philippé; Barbara De Moerloose; Tim Lammens
Journal:  Cancer Immunol Immunother       Date:  2021-05-29       Impact factor: 6.968

Review 7.  Insights into the molecular profiles of adult and paediatric acute myeloid leukaemia.

Authors:  Myint Myat Khine Aung; Megan L Mills; Joana Bittencourt-Silvestre; Karen Keeshan
Journal:  Mol Oncol       Date:  2021-02-11       Impact factor: 6.603
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.